United States CARES Act: Relief From Symptoms, Not A Cure
President Trump signed a $2.1 trillion Coronavirus Disease (COVID-19) relief bill into law on Friday, March 27. The Coronavirus Aid, Relief, and Economic Security (CARES) Act represents the third phase of federal government efforts to lend financial support to households, businesses, and state/local governments affected by the outbreak. During the relatively brief period of negotiations around the bill, the size of the support package increased dramatically in tandem with explosive growth in the number of newly confirmed cases, and a cascade of state and local restrictions shuttering schools and businesses across the country. With social distancing guidelines extended until end-April and confirmed cases continuing to grow at a rapid pace, discussions around a fourth package have already commenced.
DBRS Morningstar is a global credit ratings business with 700 employees in eight offices globally. DBRS and Morningstar Credit Ratings are committed to empowering investor success, serving the market through leading-edge technology and raising the bar for the industry.
Together, we are the world’s fourth largest credit ratings agency and a market leader in Canada, the U.S. and Europe in multiple asset classes. We rate more than 2,600 issuers and 54,000 securities worldwide and are driven to bring more clarity, diversity and responsiveness to the ratings process. Our approach and size provide the agility to respond to customers’ needs, while being large enough to provide the necessary expertise and resources. For more details visit us at dbrs.com.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.